Behind every name for a business, product or prescription drug is someone writing hundreds of possible names. Lieba Golden-Koulendros has made a career out it.

The generic drug industry in the U.S. has saved people billions and billions of dollars. But it faces new economic pressure today.

This is how Varda Space Industries hopes to commercialize manufacturing in space.

The Swiss grocery giant bought the maker of Palforzia as part of an effort to take Nestle into the profitable health and wellness space.

The drug maker announced it’s cutting the price of its most commonly-used insulins by 70%, and capping patients’ out-of-pocket cost at $35 at certain participating pharmacies.

The health policy reform is part of the Democrats’ Inflation Reduction Act, which could aid 48 million Medicare recipients.

Government insurer won’t cover Aduhelm’s $28,000-a-year price tag except for clinical trials.

The stockpile is a way to address shortages of some medicines. Some of the ingredients will be stored for emergency use.

The antibiotics sector needs a revitalizing shot. The U.S. government’s response to COVID may hold some answers.

The Trump administration has given Kodak hundreds of millions of dollars to produce chemicals for COVID-19 treatments. But the venerable photography company will have to compete with a global supply chain.